Medication leaflets

Active substance

Results for the substance sotatercept

4 results

About this active substance

Sotatercept is an investigational medication used for the treatment of pulmonary arterial hypertension (PAH). It works by modulating the TGF-beta signaling pathway, reducing pulmonary arterial pressure and improving cardiopulmonary function.

The medication is administered as a subcutaneous injection, as directed by a doctor, usually once every few weeks. It is important for patients to be monitored to assess the efficacy and safety of the treatment.

Patients should be aware of potential side effects, such as injection site pain, fatigue, or dizziness. It is important to inform the doctor of any unusual symptoms.

Common side effects include injection site pain, fatigue, and dizziness. In rare cases, severe reactions such as systemic hypertension or allergic reactions may occur. Patients should be informed of these risks before starting treatment.